Pharmacy compliance director pleads guilty over mislabeled drugs
The former director of compliance for a compounding pharmacy company pleaded guilty last week to introducing adulterated drugs into interstate commerce and conspiracy to defraud the United States by obstructing the Food and Drug Administration’s lawful functions.
Related articles
-
ArticleFinCEN cuts off 10 Mexican casinos from U.S. financial system for laundering cartel drug money
Ten Mexican cartels will be severed from the U.S. financial system for laundering money for the Sinaloa Cartel criminal organization, according to the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN).
-
ArticleU.K. outlines AI sandbox plan as regulators weigh compliance risks
The U.K. has set out a new blueprint for AI regulation, which aims to slash bureaucracy and ramp up the safe adoption of new and emerging technology to unlock potential and boost investment.
-
ArticleDOJ dismisses indictment against Cassava advisor amid legal flaws
The DOJ dropped a June 2024 indictment against a Cassava Sciences advisor, closing a case tied to an alleged short-selling scheme and related government probes. The case was criticized for fundamental flaws in evidence and legal procedures.